Collaborative leadership in transplantation: Blending clinical, business, and regulatory roles.
CMS
OPTN
foundations for success
leadership
multidisciplinary teams
organ transplant
quality
regulatory
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
revised:
16
08
2023
received:
18
05
2023
accepted:
05
09
2023
medline:
13
11
2023
pubmed:
25
9
2023
entrez:
25
9
2023
Statut:
ppublish
Résumé
Transplantation is a high-risk, high-cost treatment for end-stage diseases and is the most strictly regulated area of healthcare in the United States. Thus, achieving success for patients and the program requires skillful and collaborative leadership. Various factors, such as outcomes, volume, and financial health, may measure the success of a transplant program. Strong collaboration between clinical and administrative leaders is key to achieving and maintaining success in those three categories. Clinical leaders of adult programs, such as medical and surgical directors, bear the primary responsibility for a program's volume, outcomes, and patient safety, while administrative directors are focused on business intelligence and regulatory compliance. This paper aims to provide readers with insights into the critical role of collaborative leadership in running a successful program, with a focus on clinical, business, and regulatory perspectives.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15126Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
OPTN Board adopts New Transplant Program Performance Metrics-OPTN. Organ Procurement and Transplantation Network. (2021). Retrieved December 12, 2022, from https://optn.transplant.hrsa.gov/news/optn-board-adopts-new-transplant-program-performance-metrics
The Task S Initiative (srtr.org). Accessed March 16, 2023.
OPTN Final Rule 121.11 (b)</number> (iv) eCFR: 42 CFR 121.11.Record maintenance and reporting requirements. Accessed March 19, 2023
Wiseman AC, Akalin E, M Dadhania D, et al. Defining the roles and responsibilities of the kidney transplant medical directors: a necessary step for future training, mentoring, and professional development. Am J Transplant. 2021;21(4):1556-1563. doi:10.1111/ajt.16332
Singh N, Friedewald J, Bloom R, et al. Transplant administration- a survey of the roles and responsibilities of kidney and pancreas medical directors of US transplant centers. Clin Transplant. 2021;35(6):e14305. doi:10.1111/ctr.14305
Ibarra H, Hansen MT. Are you a collaborative leader? Harv Bus Rev. 2011 Jul-Aug;89(7-8):68-74, 164.
Hass M, Mortensen M. The secrets of great teamwork. Harv Bus Rev. 2016;94(6):70-76.
OPTN kidney Waiting List Management Tool. Accessed December 12, 2022 https://portal.unos.org/dataportal/VisualAnalytics
OPTNSRTR Annual Data Report SRTR-The Scientific Registry of Transplant Recipients (hrsa.gov). Accessed March 19, 2023
Leppke S, Leighton T, Zaun D, et al. Scientific registry of transplant recipients: collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev (Orlando). 2013;27(2):50-56.
Kasiske BL, Salkowski N, Wey A, et al. Potential implications of recent and proposed changes in the regulatory oversight of solid organ transplantation in the United States. Am J Transplant. 2016;16(12):3371-3377.
Snyder JJ, Salkowski N, Zaun D, et al. New quality monitoring tools provided by the scientific registry of transplant recipients: CUSUM. Am J Transplant. 2014;14(3):515-523.
CMS Conditions of Participation §482.96 Condition of Participation: Quality Assessment and Performance Improvement (QAPI) Accessed March 19, 2023
Quality Assessment and Performance Improvement (QAPI) Requirement D.4 OPTN Bylaws effective Dec 5, 2022 (hrsa.gov). Accessed March 19, 2023
482.70 Definitions Adverse Events. Federal Register 2007 Rules and Regulations. 72(61):15274
Zavala E, Makenzie C. The finance of kidney transplantation. Ramirez and McCauley Contemporary Kidney Transplantation. Springer International Publishing Co; 2018. doi:10.1007/978-3-319-19617-6_31
Kizer KW, English RA, Hackman M. Realizing the promise of equity in the organ transplantation system. National Academies of Sciences, Engineering and Medicine (NASEM Report); 2022.
Thomas D, Milton J, Cigarroa FG. The advancing american kidney health. JAMA. 2019;322(17):1645-1646. doi:10.1001/jama.2019.14500
The University of Michigan Kidney Epidemiology and Cost Center. (2021). Guide to the FY 2022 dialysis facility reports-dialysisdata.org. Dialysis Data. Retrieved January 8, 2023, from https://www.dialysisdata.org/sites/default/files/content/Methodology/FY2022_
U.S. Department of Health and Human Services: Advancing American kidney health. Accessed March December 12, 2022 https://aspe.hhs.gov/system/files/pdf/262046/AdvancingAmericanKidneyHealth.pdf
Klesney-Tait JA, Parekh K. Diamonds in the rough: identification of usable donor lungs. Am J Respir Crit Care Med. 2013;188(4):410-412. doi:10.1164/rccm.201306-1185ED
Machuca TN, Cypel M. Ex vivo lung perfusion. J Thorac Dis. 2014;6(8):1054-1062. doi:10.3978/j.issn.2072-1439.2014.07.1251
CUSUM reports (secure site) SRTR-Current Release (hrsa.gov) Accessed March 19, 2023 https://securesrtr.transplant.hrsa.gov/srtr-reports/cusum-charts
OPTN. Understanding the risk of transmission of HIV, Hepatitis B, and Hepatitis C from U.S. PHS Increased Risk Donors. 2017;2:1-9. https://optn.transplant.hrsa.gov/media/2171/dtac_boardreport_201706.pdf
Abara WE, Collier MG, Moorman A, et al. Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses-United States, 2010-2017. MMWR Morb Mortal Wkly Rep. 2019;68(3):61-66. https://www.cdc.gov/nchs/data/databriefs/db294.pdf
Fredrick J, Blumberg E, Brennan D, et al. Advisory Committee on Blood and Tissue Safety and Availability. April 16, 2019 Meeting Summary-Formulation of Committee Findings and Recommendations.
Sapiano MRP, Jones JM, Bowman J, et al. Impact of US Public Health Service increased risk deceased donor designation on organ utilization. Am J Transplant. 2019;19(9):2560-2569. doi:10.1111/ajt.15388
Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27(5):2893-2894. PMID: 7482956.
American College of Physician. Ethics, determination of death, and organ transplantation in normothermic regional perfusion (NRP) with controlled donation after circulatory determination of death (cDCD): American College of Physicians Statement of Concern; 2021:1-6. https://www.acponline.org/acp_policy/policies/ethics
Parent B, Caplan A, Moazami N. Response to American College of Physician's statement on the ethics of transplant after normothermic regional perfusion. Am J Transplant. 2022;22(5):1307-1310. doi:10.1111/ajt.16947
Kwong A, Kim WR, Lake JR, et al. OPTN/SRTR 2018 Annual data report: liver. Am J Transpl. 2020;20(Suppl S1):193-299. doi:10.1111/ajt.15674
Holm AM, Courtwright A, Olland A, et al. ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD). J Heart Lung Transplant. 2019;38(12):1235-1245. doi:10.1016/j.healun.2022.03.005
Reich DJ, Mulligan DC, Abt PL, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. ASTS; 2009 Sep;9(9):2004-2011. doi:10.1111/j.1600-6143.2009.02739
Orolowski J. Surgical Skills Webinar Series: Donation after Circulatory Death (DCD) Webinar. 2021. 10/19/2021.
Siddiqui F, Al-Adwan Y, Subramanian M, et al. Contemporary considerations in solid organ transplantation utilizing DCD donors. Transplant Rep. 2022:100118. doi:10.1016/j.tpr.2022.100118
Cypel M, Yeung JC, Donahoe L, et al. Normothermic ex vivo lung perfusion: does the indication impact organ utilization and patient outcomes after transplantation? J Thorac Cardiovasc Surg. 2020;159(1):346-355. doi:10.1016/j.jtcvs.2019.06.123
Loor G, Warnecke G, Villavicencio MA, et al. Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with Organ Care System on donor lung use for transplantation from extended-criteria (EXPAND): a single-arm, pivotal trial. Lancet Respir Med. 2019(1):975-984. doi:10.1016/S2213-2600(19)30200-0
Markmann JF, Abouljoud MS, Ghobrial RM, et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant. The OCS liver PROTECT randomized clinical trial. JAMA Surg. 2022;157(3):189-198. doi:10.1001/jamasurg.2021.6781
Hoffman JRH, McMaster WG, Rali AS, et al. Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion. J Heart Lung Transplant. 2021;40(11):1408-1418. doi:10.1016/j.healun.2021.06.022
Mora V, Ballesteros MA, Naranjo S, et al. Lung transplantation from controlled donation after circulatory death using simultaneous abdominal normothermic regional perfusion: a single center experience. Am J Transplant. 2022;22(7):1852-1860. doi:10.1111/ajt.17057
Griffith BP, Goerlich CE, Singh AK, et al. Genetically modified porcine-to-human cardiac xenotransplantation. N Engl J Med. 2022;387:35-44. doi:10.1056/NEJMoa2201422
Organ Procurement and Transplantation Network: Policies. Accessed on March 25, 2023 http://optn.transplant.hrsa.gov/governance/policies/
Jackson WE, Malamon JS, Kaplan B, et al. Survival benefit of living donor liver transplant. JAMA Surg. 2022;157(10):926-932. doi:10.1001/jamasurg.2022.3327
Lentine KL, Tanaka T, Xiao H, et al. Variation in adult living donor liver transplantation in the United States: identifying opportunities for increased utilization. Clin Transplant. 2023;37(7):e14924.
Kasiske BL, Lentine KL, Ahn Y, et al. OPTN/SRTR 2020 annual data report: living donor collective. Am J Transplant. 2022;22(Suppl 2):553-586. doi:10.1111/ajt.16983
Kidney disease: improving global outcomes (KDIGO) living kidney donor work group. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation. 2017, 101(Suppl 8S), S1-S109
LaPointe RD, Hays R, Baliga P, et al. Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant. 2015;15(4):914-922. doi:10.1111/ajt.13173
Kasiske BL, Asrani SK, Dew MA, et al. Living donor collective participants. the living donor collective: a scientific registry for living donors. Am J Transplant. 2017;17(12):3040-3048. doi:10.1111/ajt.14365
Kasiske BL, Ahn YS, Conboy M, et al. Outcomes of living kidney donor candidate evaluations in the living donor collective pilot registry. Transplant Direct. 2021;7(5):e689.
Park C, Jones MM, Kaplan S, et al. A scoping review of inequities in access to organ transplant in the United States. Int J Equity Health. 2022;21(1):22.
Al Ammary F, Yu Y, Ferzola A, et al. The first increase in live kidney donation in the United States in 15 years. Am J Transplant. 2020;20(12):3590-3598.
Chipman V, Cooper M, Thomas AG, et al. Motivations and outcomes of compatible living donor-recipient pairs in paired exchange. Am J Transplant. 2022;22(1):266-273.
OPTN/SRTR 2021 Annual Data Report SRTR-The Scientific Registry of Transplant Recipients (hrsa.gov) Accessed July 14, 2023.
Jesse MT, Jackson WE, Liapakis AM, et al. Living donor liver transplant candidate and donor selection and engagement: meeting report from the living donor liver transplant consensus conference. Clin Transplant. 2023;37:e14954.
CMS Conditions of Participation §482.90/482.94. Condition of Participation: Patient and Living Donor Selection; Patient and Living Donor Management. Accessed July 14, 2023
Membership Requirements for Transplant Hospitals and Transplant Programs Appendix D OPTN Bylaws effective Dec 5, 2022 (hrsa.gov) accessed July 14;2023
Klesney-Tait J, Eberlein M, Geist L, et al. Starting a lung transplant program. a roadmap for long-term excellence. chest. 2015;147(5):1435-1443. doi:10.1378/chest.14-2241
Valapour M, Lehr CJ, Skeans MA, et al. OPTN/SRTR 2020. Annual Data Report: lung. Am J Transplant. 2022;22(2):432-518. doi:10.1111/ajt.16991
Wever-Pinzon O, Drakos SG, Kfoury AG, et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United Network for Organ Sharing Thoracic Organ Allocation Policy justified? Circulation. 2013;127(4):452-462.
OPTN Public Comment Document. Proposal to modify the Adult Heart Allocation System. https://optn.transplant.hrsa.gov/media/1921/thoracic_adult_heart_allocation_modification_20160815.pdf Published August 2016. Accessed March, 15;2020.
Valapour M, Lehr CJ, Wey A, et al. Expected effect of the lung composite allocation score system on US lung transplantation. Am J Transplant. 2022;22(12):2971-2980.
Wu C, Evans I, Joseph R, et al. Comorbid conditions in kidney transplantation: association with graft and patient survival. J Am Soc Nephrol. 2005;16:3437-3444.
Cicek SK, Akinci O, Ergun S, et al. Comparison of survival in recipients of marginal and standard cadaveric donor kidneys. Transplant Proc. 2023;55(1):87-92.
Baganate F, Beal EW, Turmin D, et al. Early mortality after liver transplantation: defining the course. Surgery. 2018;164(4):694-704.